CORBUS PHARMACEUTICALS HOLDI

Ben Yong Sells 2,000 Shares of Corbus Pharma: What Investors Should Watch

Ben Yong’s 2,000‑share sale at Corbus Pharmaceuticals shows a neutral insider signal, urging investors to watch upcoming clinical results and market shifts.

CORBUS PHARMACEUTICALS HOLDI
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

15/09/2026, 23:15

3 minutes to read

Corbus Pharma Awards CMO 250k Shares and Options to Boost Pipeline Confidence

Corbus Pharma’s CMO receives a 58k‑share RSU and 192k‑share option grant—signaling executive confidence as lenabasum advances clinical milestones.

CORBUS PHARMACEUTICALS HOLDI
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

17/08/2026, 22:47

4 minutes to read